Takeda Pharmaceutical Company Limited (TAK)
NYSE: TAK · Real-Time Price · USD
14.06
+0.20 (1.44%)
Feb 21, 2025, 4:00 PM EST - Market closed
Takeda Pharmaceutical Market Cap
Takeda Pharmaceutical has a market cap or net worth of $44.74 billion as of February 21, 2025. Its market cap has increased by 0.69% in one year.
Market Cap
44.74B
Enterprise Value
77.78B
1-Year Change
0.69%
Ranking
Category
Stock Price
$14.06
Market Cap Chart
Since January 5, 2010, Takeda Pharmaceutical's market cap has decreased from $71.21B to $44.74B, a decrease of -37.17%. That is a compound annual growth rate of -3.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 44.58B | 5.81% |
| Dec 31, 2024 | 42.13B | -5.91% |
| Dec 29, 2023 | 44.78B | -7.43% |
| Dec 30, 2022 | 48.37B | 13.50% |
| Dec 31, 2021 | 42.62B | -24.84% |
| Dec 31, 2020 | 56.70B | -8.18% |
| Dec 31, 2019 | 61.76B | 134.31% |
| Dec 31, 2018 | 26.36B | -59.21% |
| Dec 30, 2016 | 64.61B | -22.54% |
| Dec 31, 2015 | 83.40B | 20.68% |
| Dec 31, 2014 | 69.11B | -9.90% |
| Dec 31, 2013 | 76.71B | 3.69% |
| Dec 31, 2012 | 73.97B | 0.68% |
| Dec 30, 2011 | 73.47B | -9.45% |
| Dec 31, 2010 | 81.14B | 13.94% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 780.72B |
| UnitedHealth Group | 470.30B |
| Johnson & Johnson | 380.14B |
| Novo Nordisk | 370.06B |
| AbbVie | 348.39B |
| Abbott Laboratories | 229.17B |
| AstraZeneca | 228.16B |
| Intuitive Surgical | 217.02B |